| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.096 | 0.08 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |